Skip to main content
. 2020 Nov 19;17(11):e1003393. doi: 10.1371/journal.pmed.1003393

Fig 1. Study flowchart.

Fig 1

AA, artesunate-amodiaquine; ACT, artemisinin-based combination therapy; AL, artemether-lumefantrine; AM, artesunate-mefloquine; DP, dihydroartemisinin-piperaquine; WWARN, WorldWide Antimalarial Resistance Network.